Search Results 1201-1210 of 21688 for Inhibition

1. Effect of Topical Phenylephrine 2.5% on EVP in Normal Human Eyes - Mayo Clinic

   ... inhibitors, and systemic steroids. Participation in any interventional study within the past 30 days prior to study visit. Women who are pregnant ...

2. An Extension Study To Evaluate Long-term Safety Of Sacubitril/Valsartan In Pediatric Patients With Heart Failure (HF) - Mayo Clinic

   History of hypersensitivity or allergy to study treatment, its excipients or drugs of similar chemical class, ACEIs, ARBs, or NEP inhibitor and known/suspected ...

3. Auranofin and Sirolimus in Treating Participants With Ovarian Cancer - Mayo Clinic

   Unable to discontinue use of a strong CYP3A4 inhibitor. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for ...

4. LEGEND Study: A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients With BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) and High-Risk NMIBC Patients Who Are BCG Naïve or Received Incomplete BCG Treatment - Mayo Clinic

   Patients who have previously been treated with an investigational or approved checkpoint inhibitor ... History of interstitial lung disease and/or pneumonitis in ...

5. Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Mayo Clinic

   Anticoagulation with Phenprocoumon, warfarin, or a direct thrombin inhibitor. Chronic atrial fibrillation. Any episode of atrial fibrillation within the ...

6. Study of Pembrolizumab Combined with Decitabine and Pralatrexate in Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma - Mayo Clinic

   Had prior therapy with PD-1 inhibitors. Has a diagnosis of immunodeficiency or has been receiving any immunosuppressive therapy within 7 days prior to the ...

7. Tissue Repair and Regeneration: Mechanisms Underlying Cellular Senescence and Acute Skeletal Injury - Mayo Clinic Research

   ... inhibitors. Dr. Chandra's Bone Injury and Repair Lab also investigates the role of senescent cells and their secretome in regulating acute skeletal injury ...

8. A Study of Selpercatinib to Treat Participants with RET-Mutant Medullary Thyroid Cancer - Mayo Clinic

   ... inhibitors for advanced/metastatic disease. Patients with mixed histology ... Prior systemic treatment with kinase inhibitor(s); Are taking a ...

9. A Study to Test the Effectiveness and Safety of Padsevonil as Treatment of Focal-onset Seizures in Adult Subjects with Drug-resistant Epilepsy - Mayo Clinic

   ... inhibitors of the CYP3A4 or 2C19 pathway for 2 weeks (or 5 half-lives, whichever is longer) prior to the Baseline Visit. Subjects taking sensitive ...

10. A Study To Assess The Safety And Effectiveness Of FLX-787 In Subjects With Charcot-Marie-Tooth Disease Experiencing Muscle Cramps. - Mayo Clinic

    ... inhibitors), or oral or esophageal lesions/ulcers; Presence of significant swallowing problems; Unable or unwilling to discontinue medications for cramps and ...